Project Grant S10OD036395

Award Date 9/1/24
Completion Date 8/31/25
Dollars Obligated $353K
Funding Federal Agency
Office of the Director
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
This federal Project Grant award from the National Institutes of Health (NIH) Research Infrastructure Programs (CFDA 93.351) provides $472,723 to Drexel University to acquire a BD Biosciences Symphony A5 spectrally enabled flow cytometer with 5 lasers, 48 fluorescence and 2 scatter channels, and a high-throughput sampler system. This state-of-the-art flow cytometer will become the flagship instrument for Drexel's newly created Flow Cytometry Core Facility, supporting deep profiling of cellular...
This $350,000 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) will fund the acquisition of a BD FACSymphony S6 flow cytometer for the University of Toledo Flow Cytometry Core. The new instrument will replace the university's 16-year-old flow cytometer, providing enhanced capabilities for NIH-funded research projects in molecular biology, pathology, virology, immunology, and cell biology across the...
This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (ORIP) provides $490,899 to The Johns Hopkins University to acquire a BD FACSAria Fusion cell sorter. This advanced 4-laser, 16-detector flow cytometry instrument will significantly enhance the research capabilities of 22 NIH-funded user groups at the university's Ross Flow Cytometry Core facility. The new cell sorter will replace an aging 3-laser instrument and address unmet needs...
This federal Project Grant award of $634,038 from the National Institutes of Health (CFDA 93.351 - Research Infrastructure Programs) will provide the University of California, Davis with a BD FACSymphony S6 flow cytometric sorter. This instrument will be integrated into the university's established Flow Cytometry Core facility to support over 20 current NIH-funded research projects spanning basic, translational, and clinical research areas, including studies on therapeutic HIV vaccines, SIV...
This Project Grant award of $538,834 from the National Institutes of Health (NIH) Research Infrastructure Programs (CFDA 93.351) will enable the University of Iowa Flow Cytometry Facility to acquire a Cytek Amnis ImageStreamX MKII Imaging Cytometer. This specialized instrument will provide NIH-funded investigators and other researchers at the University of Iowa with access to advanced imaging and quantitative capabilities that are currently inaccessible, as the nearest public imaging cytometer...
This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $239,530 to the University of California, Davis (UC Davis) to acquire a Beckman Coulter CytoFlex Nano flow cytometer. The new cytometer will enable UC Davis researchers at the Comprehensive Cancer Center to study nano-scale extracellular vesicles, such as exosomes, which play a key role in cancer diagnosis, metastasis, and treatment. The existing flow...
The National Institutes of Health (NIH) Office of Research Infrastructure Programs (ORIP) awarded a $454,942 Project Grant (CFDA 93.351 - Research Infrastructure Programs) to the University of California, San Diego (UC San Diego) on May 15, 2025. The grant will fund the acquisition of a Cytek Aurora full-spectrum flow cytometer with 5 lasers, 63 parameters, and 96-well plate high-throughput sample acquisition capabilities. This state-of-the-art instrument will be housed in the university's Human...
The National Institute of General Medical Sciences (NIGMS) awarded a $243,119 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Puerto Rico Medical Sciences Campus (UPR-MSC). This award will enable the purchase of a state-of-the-art BD FACSymphony A1 flow cytometer with 4 lasers to support health-related research projects and educational needs at UPR-MSC. The flow cytometer will allow for the advanced analysis of immune cells and other...
This Project Grant award, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), provides $478,832 to the MaineHealth Institute for Research (MHIR) to acquire a BD FACSymphony A5 SE flow cytometry system. This high-dimensional instrument will significantly enhance MHIR's research capabilities by enabling advanced analysis of cells and extracellular vesicles, supporting ongoing NIH-funded studies and...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) will provide $208,915 to St. Mary's University of San Antonio, Texas to acquire a Beckman Coulter CytoFLEX flow cytometry instrument. The instrument will be housed in a collaborative lab space at the university to support scientific research and educational projects across basic, translational, and biomedically-related disciplines. The...

This federal Project Grant award from the National Institutes of Health's Research Infrastructure Programs (CFDA 93.351) provides $353,235 to The Johns Hopkins University to acquire a CytoFLEX LX flow cytometer instrument. The new instrument will replace an outdated BD FACSCalibur and enable significantly expanded experimental capabilities for the university's Integrated Imaging Center. Key upgrades include more lasers, increased analysis parameters, small particle detection, and a multi-well plate autoloader. This enhanced flow cytometry system will support a range of ongoing research projects at Johns Hopkins, including work on nanoparticle cancer treatments, Alzheimer's disease, photoreceptor development, epigenomics, and nucleic acid nanotube tumor therapies. The new instrument is expected to improve experimental productivity and generate higher quality data to accelerate the translation of emerging biomedical discoveries from the lab to the clinic. The award period runs from September 1, 2024 to August 31, 2025.

Generated 7/1/25, 4:30 AM